Krebs Biochemicals and Industries Limited (NSE: KREBSBIO), ISIN INE268B01013 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
KREBSBIO last traded at ₹54.39 (+1.44%), with a 52-week range of ₹38.52 to ₹81.80 (as of 30 Jul 2026).
Shareholding as of Mar 2026: promoters 72.74%, FIIs 0.50%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 53/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.